Physician profile
Justin E Hugo
NPI 1104826098
$4,056.53
in general payments reported to CMS, 2019-2025
40 companies · $1,411 in 2025
The $1,411 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,105 · 2020: $249 · 2022: $99.34 · 2023: $422 · 2024: $770 · 2025: $1,411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,603.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $779.66 | 2022-2025 | |
| Lilly USA, LLC | $484.53 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $416.55 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $370.58 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $257.54 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $189.29 | 2019-2025 | Evenity, Prolia, Repatha |
| Janssen Pharmaceuticals, INC | $182.84 | 2019-2025 | Xarelto, Spravato |
| Glaxosmithkline, LLC. | $134.94 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Opko Pharmaceuticals, LLC | $125.00 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.09 | 2019-2023 | |
| Otsuka America Pharmaceutical, INC. | $90.67 | 2019-2023 | Jynarque |
| Boston Scientific Corporation | $64.86 | 2024 | Bodyguardian |
| Axsome Therapeutics, INC. | $64.45 | 2025 | Symbravo, Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $59.02 | 2025 | Caplyta |
| Fresenius USA Marketing, INC. | $59.00 | 2019-2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Hugo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.